BR0315219A - Método para a purificação de um lantibiótico - Google Patents

Método para a purificação de um lantibiótico

Info

Publication number
BR0315219A
BR0315219A BR0315219-7A BR0315219A BR0315219A BR 0315219 A BR0315219 A BR 0315219A BR 0315219 A BR0315219 A BR 0315219A BR 0315219 A BR0315219 A BR 0315219A
Authority
BR
Brazil
Prior art keywords
lantibiotic
purification
lantibiotics
nisin
dictate
Prior art date
Application number
BR0315219-7A
Other languages
English (en)
Inventor
Richard T Coughlin
Joseph H Crabb
Original Assignee
Immucell Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immucell Corp filed Critical Immucell Corp
Publication of BR0315219A publication Critical patent/BR0315219A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

"MéTODO PARA A PURIFICAçãO DE UM LANTIBIóTICO". Trata-se de um método para a purificação de um lantibiótico a partir de uma solução bruta ou parcialmente purificada contendo o lantibiótico. Em modalidades preferidas, o lantibiótico é nisina, embora as características estruturais comuns de lantibióticos ditem a eficácia dos métodos de purificação descritos para outros membros do gênero lantibiótico. O método inclui a etapa de formar uma mistura de incubação compreendendo a solução contendo o lantibiótico e uma enzima proteolítica e incubar a mistura sob condições otimizadas para atividade proteolítica seletiva.
BR0315219-7A 2002-10-09 2003-10-07 Método para a purificação de um lantibiótico BR0315219A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/268,037 US6794181B2 (en) 2002-10-09 2002-10-09 Method of purifying lantibiotics
PCT/US2003/031986 WO2004033704A1 (en) 2002-10-09 2003-10-07 Method of purifying lantibiotics

Publications (1)

Publication Number Publication Date
BR0315219A true BR0315219A (pt) 2005-08-23

Family

ID=32068478

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0315219-7A BR0315219A (pt) 2002-10-09 2003-10-07 Método para a purificação de um lantibiótico

Country Status (12)

Country Link
US (1) US6794181B2 (pt)
EP (1) EP1549757A4 (pt)
JP (1) JP2006501854A (pt)
KR (1) KR20050072433A (pt)
CN (1) CN1703518A (pt)
AU (1) AU2003279208A1 (pt)
BR (1) BR0315219A (pt)
CA (1) CA2501635A1 (pt)
CR (1) CR7783A (pt)
MX (1) MXPA05003713A (pt)
WO (1) WO2004033704A1 (pt)
ZA (1) ZA200502822B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1686185A4 (en) * 2003-11-07 2007-03-07 Ajinomoto Kk METHOD FOR THE PRODUCTION OF A BACTERIOCIN-CONTAINING MILKY ACID BACTERIA CULTURE AND METHOD FOR LIVING FOOD STORAGE USING THEREOF
US20090215985A1 (en) * 2005-08-12 2009-08-27 Oragenics, Inc. Differentially protected orthogonal lanthionine technology
CA2618066A1 (en) * 2005-08-12 2007-02-22 Oragenics, Inc. Differentially protected orthogonal lanthionine technology
KR20080106545A (ko) * 2006-02-13 2008-12-08 베링거잉겔하임베트메디카게엠베하 란티바이오틱의 제조 방법
WO2007103548A2 (en) 2006-03-09 2007-09-13 Inflazyme Pharmaceuticals Ltd. Novel antibiotic compositions
EP2267003A1 (en) * 2009-06-24 2010-12-29 Applied NanoSystems B.V. Biologically produced cyclic affinity tags
EP2799068A1 (en) 2013-05-01 2014-11-05 National University of Ireland, Galway Antimicrobial compositions and methods for their production
US10023617B1 (en) * 2018-01-11 2018-07-17 Immucell Corporation Methods and systems of producing pharmaceutical grade lantibiotics

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4900677A (en) * 1986-09-26 1990-02-13 E. I. Du Pont De Nemours And Company Process for rapid isolation of high molecular weight DNA
JP2794305B2 (ja) * 1988-07-20 1998-09-03 明治乳業株式会社 牛乳乳清蛋白質中のβ―ラクトログロブリンの選択的酵素分解方法
JPH0724578B2 (ja) * 1990-09-17 1995-03-22 雪印乳業株式会社 ナイシン生産性微生物及びそれを使用するナイシンの生産方法
GB2254852B (en) * 1991-04-11 1995-04-05 Thomae Gmbh Dr K Lantibiotic isolation and purification by plural chromatography processes
US5451369A (en) * 1992-05-13 1995-09-19 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Bacteriocidal surfaces and articles with attached bacteriocin
JP3112597B2 (ja) * 1993-03-16 2000-11-27 雪印乳業株式会社 低アレルゲン性乳蛋白質の製造法
US5650320A (en) * 1994-04-20 1997-07-22 University Of Alabama At Birmingham Research Foundation Lanthionine antibiotic compositions and methods
JP3364551B2 (ja) * 1995-03-03 2003-01-08 天野エンザイム株式会社 低アレルゲン性乳蛋白質の製造法
US5804684A (en) * 1995-08-24 1998-09-08 The Theobald Smith Research Institute, Inc. Method for isolating nucleic acids
JP3289770B2 (ja) * 1996-03-28 2002-06-10 不二製油株式会社 蛋白分解物及びその製造方法
JP3269519B2 (ja) * 1996-03-28 2002-03-25 不二製油株式会社 大豆蛋白分解物及びその製造方法
JPH1156250A (ja) * 1997-08-27 1999-03-02 Fuji Oil Co Ltd 蛋白分解物及びその製造方法

Also Published As

Publication number Publication date
WO2004033704A1 (en) 2004-04-22
EP1549757A1 (en) 2005-07-06
KR20050072433A (ko) 2005-07-11
AU2003279208A1 (en) 2004-05-04
JP2006501854A (ja) 2006-01-19
US6794181B2 (en) 2004-09-21
MXPA05003713A (es) 2005-09-30
CR7783A (es) 2005-10-05
CN1703518A (zh) 2005-11-30
ZA200502822B (en) 2006-11-29
US20040072333A1 (en) 2004-04-15
CA2501635A1 (en) 2004-04-22
EP1549757A4 (en) 2006-03-15

Similar Documents

Publication Publication Date Title
BG103694A (bg) Метод за получаване и пречистване на n- алкилирано аспарагиново производно
TR200101859T2 (tr) Kemokin alıcı aktivitesinin modülatörleri olarak N-üreidoalkil-piperidinler
PT758341E (pt) Inibidores do factor xa
NO20052928L (no) Nye kjemiske forbindelser
DE60027135D1 (de) Inhibitoren für wachstumdifferenzierungsfaktor und ihre anwendungen
BR9908280A (pt) Inibidores de enzimas de fosfolipase
TR200001954T2 (tr) Faktör XA'nın önleyicileri olarak indol türevleri.
FI942423A0 (fi) Sakkariinijohdannisia proteolyyttisen entsyymin inhibiittoreina
EP1333032A4 (en) METHOD FOR PURIFYING ANTIBODIES
DE69926919D1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
ATE449104T1 (de) Verfahren zur reinigung von fibrinogen
BR0315219A (pt) Método para a purificação de um lantibiótico
ATE344321T1 (de) Verfahren zur aufreinigung von bakterienzellen und zellbestandteilen
EP1509220A4 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SEBORRHOE WITH 4-HYDROXY-5-METHOXY-4-2-METHYL-3 (3-METHYL-2-BUTENYL) -2-OXIRANYL-1-OXASPIRO 2.5 OCTAN-6-ON
FI950044A0 (fi) Menetelmä proteiini C:n hajoamisen estämiseksi
DE60001579D1 (de) Verfahren zur behandlung organischer substanzen
Lee et al. FK-506 binding protein from tolypocladium inflatum: Resistance of FKBPFK-506 complex against proteolysis
ATE498692T1 (de) Verfahren zur bestimmung der aktivität von ornithine decarboxylase und zum identifizieren von effektoren der ornithine decarboxylase aktivität
NO20014372D0 (no) Isolering og delvis karakterisering av en ny antiprokferativ komponent fra humane leukocytter
MXPA02010182A (es) Metodos de uso de penicilaminas para el tratamiento de condiciones que resultan del dano en el adn.
TH65142A (th) กรรมวิธีเชิงเอนไซม์สำหรับการแยกอีแนนซิโอเมอร์ของกรดอะมิโน
ITRM20020151A0 (it) Sistema di trattamento per la rimozione biologica di nutrienti da reflui di origine civile o mista.
ATE308315T1 (de) Potentierungsmedium

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A , 6A , E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2073 DE 28/09/2010.